Bristol Myers Squibb Co. (BMY)
54.01
-1.27
(-2.30%)
USD |
NYSE |
Jun 18, 16:00
54.03
+0.02
(+0.04%)
After-Hours: 20:00
Bristol Myers Squibb EPS Diluted (TTM) : 3.563 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.563 |
| December 31, 2025 | 3.459 |
| September 30, 2025 | 2.962 |
| June 30, 2025 | 2.478 |
| March 31, 2025 | 2.664 |
| December 31, 2024 | -4.428 |
| September 30, 2024 | -3.597 |
| June 30, 2024 | -3.259 |
| March 31, 2024 | -3.101 |
| December 31, 2023 | 3.858 |
| September 30, 2023 | 3.943 |
| June 30, 2023 | 3.756 |
| March 31, 2023 | 3.431 |
| December 31, 2022 | 2.952 |
| September 30, 2022 | 3.068 |
| June 30, 2022 | 3.010 |
| March 31, 2022 | 2.817 |
| December 31, 2021 | 3.119 |
| September 30, 2021 | -2.402 |
| June 30, 2021 | -2.274 |
| March 31, 2021 | -2.780 |
| December 31, 2020 | -4.016 |
| September 30, 2020 | -0.1139 |
| June 30, 2020 | -0.1034 |
| March 31, 2020 | 0.809 |
| Date | Value |
|---|---|
| December 31, 2019 | 2.197 |
| September 30, 2019 | 3.476 |
| June 30, 2019 | 3.810 |
| March 31, 2019 | 3.163 |
| December 31, 2018 | 3.024 |
| September 30, 2018 | 0.8723 |
| June 30, 2018 | 0.224 |
| March 31, 2018 | 0.5512 |
| December 31, 2017 | 0.5871 |
| September 30, 2017 | 2.543 |
| June 30, 2017 | 2.745 |
| March 31, 2017 | 2.884 |
| December 31, 2016 | 2.654 |
| September 30, 2016 | 2.039 |
| June 30, 2016 | 1.744 |
| March 31, 2016 | 0.9713 |
| December 31, 2015 | 0.9676 |
| September 30, 2015 | 1.058 |
| June 30, 2015 | 1.069 |
| March 31, 2015 | 1.347 |
| December 31, 2014 | 1.201 |
| September 30, 2014 | 1.629 |
| June 30, 2014 | 1.614 |
| March 31, 2014 | 1.738 |
| December 31, 2013 | 1.543 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |
| Merck & Co., Inc. | 3.553 |
| Pfizer Inc. | 1.304 |
| AstraZeneca PLC | 3.330 |